Newborn Screening Laboratory
Newborn screening (NBS) is a public health population based screening system designed to detect and treat infants with special needs who have certain hematologic, endocrine or metabolic disorders. The goal of newborn screening is to eliminate or reduce mortality, morbidity and disabilities that result from the disorders included in the screening panel through early detection and treatment. Early detection of these disorders can prevent the infant from having seizures, physical disabilities, mental retardation, chronic illness or death. By obtaining a few drops of blood from an infant's heel, tests are performed to help find the conditions so treatment can begin early and prevent these effects.
As of July 1, 2007, Louisiana is screening for all disorders recommended by the American College of Medical Genetics (ACMG). For more information on Newborn Screening, please click on the links below:
- List of Disorders
- Sample Collection Procedures
- Genetic Disease Program
- Getting Newborn Screening Results
***NOTICE: The Policy for Early Collection and Blood Transfusion Collection has changed. Please click here for more details.
For more information, please contact the NBS lab at 225-219-5206.